SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 481 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2024. The put-call ratio across all filers is 0.46 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $4,345,000 | -47.7% | 27,500 | -57.1% | 3.66% | -32.2% |
| Q1 2024 | $8,306,413 | +22.0% | 64,162 | -9.1% | 5.40% | +40.8% |
| Q4 2023 | $6,807,958 | -28.0% | 70,600 | +339.9% | 3.83% | -39.5% |
| Q3 2023 | $9,459,560 | +109.4% | 16,050 | -51.0% | 6.34% | +90.5% |
| Q1 2023 | $4,516,689 | -48.4% | 32,770 | -51.5% | 3.33% | -38.2% |
| Q4 2022 | $8,746,650 | +90.7% | 67,500 | +62.7% | 5.38% | +172.6% |
| Q3 2022 | $4,587,000 | -42.2% | 41,500 | -30.8% | 1.98% | +39.9% |
| Q2 2018 | $7,931,000 | +478.1% | 60,000 | +20.0% | 1.41% | +176.9% |
| Q4 2016 | $1,372,000 | -75.1% | 50,000 | -44.3% | 0.51% | -75.3% |
| Q3 2016 | $5,509,000 | +37.6% | 89,700 | -57.3% | 2.07% | +7.5% |
| Q2 2016 | $4,005,000 | +38.4% | 210,000 | +180.0% | 1.92% | +39.0% |
| Q4 2015 | $2,894,000 | +184.0% | 75,000 | +136.3% | 1.38% | +134.6% |
| Q3 2015 | $1,019,000 | – | 31,744 | – | 0.59% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 87,180 | $2,581,000 | 3.60% |
| Perceptive Advisors | 1,771,029 | $52,422,000 | 2.99% |
| SPHERA FUNDS MANAGEMENT LTD. | 483,047 | $14,298,000 | 2.80% |
| HealthCor Management, L.P. | 1,550,000 | $45,880,000 | 2.10% |
| Camber Capital Management LP | 1,350,000 | $39,960,000 | 1.62% |
| Tourbillon Capital Partners, L.P. | 1,537,518 | $45,511,000 | 1.17% |
| Elk Creek Partners, LLC | 562,522 | $16,651,000 | 1.02% |
| EMERALD ADVISERS, LLC | 818,705 | $24,234,000 | 1.00% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 604,467 | $17,892,000 | 0.82% |
| Carlson Capital, L.P. | 1,845,702 | $54,633,000 | 0.70% |